Table 1.
Laboratory data of the patient
| Urinalysis | Biochemistry | ||||
|---|---|---|---|---|---|
| Protein | – | TP (g/dL) | 5.7 (6.6–8.1) | Na+ (mEq/L) | 141 (138–145) |
| Glucose | 4+ | Albumin (g/dL) | 3.9 (4.1–5.1) | K+ (mEq/L) | 3.5 (3.6–4.8) |
| WBC | 2+ | AST (IU/L) | 21 (13–30) | Cl− (mEq/L) | 108 (101–108) |
| RBC | – | ALT (IU/L) | 32 (7–23) | Ca2+ (mg/dL) | 8.7 (8.8–10.1) |
| Ketone | – | LDH (IU/L) | 150 (124–222) | Pi2− (mg/dL) | 3.6 (2.7–4.6) |
| γGTP (IU/L) | 26 (9–32) | ACTH (pg/ml) | 30.8 (7.2–63.3) | ||
| BUN (mg/dL) | 9.7 (8.0–20.0) | Cortisol (μg/dl) | 15.1 (4.5–21.1) | ||
| Complete blood count | CRE (mg/dL) | 0.45 (0.46–0.79) | LH (mIU/ml) | 6.7 | |
| WBC (× 103/μL) | 6.3 (3.3–8.6) | UA (mg/dL) | 0.6 (2.6–7.0) | FSH (mIU/ml) | 26.1 |
| RBC (× 106/μL) | 4.74 (3.86–4.92) | HDL-cho (mg/dL) | 35 (40–96) | E2 (pg/ml) | < 19 |
| Hb (g/dL) | 14.5 (11.6–14.8) | LDL-cho (mg/dL) | 87 (70–139) | Testosterone (ng/ml) | 0.11 |
| Ht (%) | 41.4 (35.1–44.4) | TG (mg/L) | 254 (30–149) | FT3 (pg/ml) | 2.76 (2.30–4.30) |
| Plt (× 104/μL) | 21.4 (15.8–34.8) | UA (mg/dL) | 0.6 (2.6–7.0) | FT4 (ng/dl) | 0.84(0.90–1.70) |
| CRP (mg/dL) | 0 (< 0.14) | GH (ng/ml) | 0.14 (0.13–9.88) | ||
| Glucose (mg/dL) | 132 | IGF-I (ng/ml) | 90 | ||
| HbA1c (%) | 10.6 | PRL (ng/ml) | 60.1 (4.90–29.3) | ||
WBC white blood cell, Hb hemoglobin, Ht hematocrit, Plt platelet, RBC red blood cell, Ret reticulocytes, TP total protein, AST aspartate aminotransferase, ALT alanine aminotransferase, LDH lactate dehydrogenase, γGTP γ-glutamyltransferase, BUN blood urea nitrogen, CRE creatinine, UA uric acid, HDL-cho high-density lipoprotein cholesterol, LDL-cho low-density lipoprotein cholesterol, TG triglyceride, UA uric acid, ACTH adrenocorticotropichormone, LH Luteinizing hormone, FSH follicle stimulating hormone E2 estradiol, FT3 free triiodothyronine, free thyroxine, GH growth hormone, IGF-I insulin-like growth factor, PRL prolactin